Exact Sciences Corp. (NASDAQ: EXAS) has acquired PreventionGenetics in a cash-cum-stock deal worth $190 million. The acquisition will mark Exact Sciences entry into hereditary cancer testing (HCT) and ...

MARSHFIELD, Wis., Aug. 5, 2020 /PRNewswire/ -- PreventionGenetics is excited to announce the availability of their new whole genome sequencing (WGS) test, PGnome ®. Prices start at only $2,490 for ...

Exact Sciences Corp., a Madison-based provider of cancer screening and diagnostic tests, has acquired PreventionGenetics, in Marshfield, for $190 million. Exact Sciences is the maker of Cologuard, a ...

MADISON, Wis., Jan. 9, 2022 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) announced today it has acquired PreventionGenetics, a genetic testing laboratory, to complement its advanced cancer ...

As a consequence of advances in genetics, demand for clinical genetic services has increased, reinforcing the need for programs toward the management and prevention of genetic diseases and birth ...